OBJECTIVE: Maternal immunization with oxidized low-density lipoprotein prior to pregnancy prevents pathogenic in utero programming by gestational hypercholesterolemia, but it is unknown whether gestational hypercholesterolemia and maternal immunization affect similar pathways. STUDY DESIGN: A lipidomic approach was used for unbiased plasma eicosanoid profiling in adult offspring of immunized and nonimmunized normocholesterolemic or hypercholesterolemic rabbit mothers. RESULTS: Gestational hypercholesterolemia was associated with increased levels of some eicosanoids formed by the cyclooxygenase and 12-lipoxygenase pathways only (including thromboxane B2, prostaglandin [PG] F2α, PGE2, and PGD2). Immunization of hypercholesterolemic or normocholesterolemic mothers reduced 9 of 14 eicosanoids of the cyclooxygenase pathway, 21 of 23 eicosanoids of the 5- and 12-lipoxygenase pathways (eg, 5-hydroxyeicosatetraenoic acid, hepoxilin B3, 12-hydroxyeicosatetraenoic acid), 8 of 19 eicosanoids of the cytochrome P-450 pathway, and all metabolites of the nonenzymatic pathway. CONCLUSION: Maternal immunization not only counteracts in utero programming by gestational hypercholesterolemia but reduces a broad range of eicosanoid modulators of immunity and inflammation in offspring.
OBJECTIVE: Maternal immunization with oxidized low-density lipoprotein prior to pregnancy prevents pathogenic in utero programming by gestational hypercholesterolemia, but it is unknown whether gestational hypercholesterolemia and maternal immunization affect similar pathways. STUDY DESIGN: A lipidomic approach was used for unbiased plasma eicosanoid profiling in adult offspring of immunized and nonimmunized normocholesterolemic or hypercholesterolemic rabbit mothers. RESULTS:Gestational hypercholesterolemia was associated with increased levels of some eicosanoids formed by the cyclooxygenase and 12-lipoxygenase pathways only (including thromboxane B2, prostaglandin [PG] F2α, PGE2, and PGD2). Immunization of hypercholesterolemic or normocholesterolemic mothers reduced 9 of 14 eicosanoids of the cyclooxygenase pathway, 21 of 23 eicosanoids of the 5- and 12-lipoxygenase pathways (eg, 5-hydroxyeicosatetraenoic acid, hepoxilin B3, 12-hydroxyeicosatetraenoic acid), 8 of 19 eicosanoids of the cytochrome P-450 pathway, and all metabolites of the nonenzymatic pathway. CONCLUSION: Maternal immunization not only counteracts in utero programming by gestational hypercholesterolemia but reduces a broad range of eicosanoid modulators of immunity and inflammation in offspring.
Authors: Maqsood M Elahi; Felino R Cagampang; Frederick W Anthony; Nick Curzen; Sunil K Ohri; Mark A Hanson Journal: Hypertension Date: 2008-02-19 Impact factor: 10.190
Authors: Raymond Deems; Matthew W Buczynski; Rebecca Bowers-Gentry; Richard Harkewicz; Edward A Dennis Journal: Methods Enzymol Date: 2007 Impact factor: 1.600
Authors: Roberto Romero; Jimmy Espinoza; Sonia Hassan; Francesca Gotsch; Juan Pedro Kusanovic; Cecilia Avila; Offer Erez; Sam Edwin; Ann Marie Schmidt Journal: J Perinat Med Date: 2008 Impact factor: 1.901
Authors: Matthew W Buczynski; Daren L Stephens; Rebecca C Bowers-Gentry; Andrej Grkovich; Raymond A Deems; Edward A Dennis Journal: J Biol Chem Date: 2007-05-29 Impact factor: 5.157
Authors: A Liguori; F P D'Armiento; A Palagiano; M L Balestrieri; S Williams-Ignarro; F de Nigris; L O Lerman; M D'Amora; M Rienzo; C Fiorito; L J Ignarro; W Palinski; C Napoli Journal: BJOG Date: 2007-09-27 Impact factor: 6.531
Authors: Nima Goharkhay; Elena Sbrana; Phyllis K Gamble; Esther H Tamayo; Ancizar Betancourt; Karina Villarreal; Gary D V Hankins; George R Saade; Monica Longo Journal: Am J Obstet Gynecol Date: 2007-10 Impact factor: 8.661
Authors: James F Markworth; Luke Vella; Benjamin S Lingard; Dedreia L Tull; Thusitha W Rupasinghe; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-10-02 Impact factor: 3.619
Authors: Nils Helge Schebb; Hartmut Kühn; Astrid S Kahnt; Katharina M Rund; Valerie B O'Donnell; Nicolas Flamand; Marc Peters-Golden; Per-Johan Jakobsson; Karsten H Weylandt; Nadine Rohwer; Robert C Murphy; Gerd Geisslinger; Garret A FitzGerald; Julien Hanson; Claes Dahlgren; Mohamad Wessam Alnouri; Stefan Offermanns; Dieter Steinhilber Journal: Front Pharmacol Date: 2022-03-02 Impact factor: 5.810